CL2020000054A1 - Proceso mejorado para preparar imetelstat. - Google Patents

Proceso mejorado para preparar imetelstat.

Info

Publication number
CL2020000054A1
CL2020000054A1 CL2020000054A CL2020000054A CL2020000054A1 CL 2020000054 A1 CL2020000054 A1 CL 2020000054A1 CL 2020000054 A CL2020000054 A CL 2020000054A CL 2020000054 A CL2020000054 A CL 2020000054A CL 2020000054 A1 CL2020000054 A1 CL 2020000054A1
Authority
CL
Chile
Prior art keywords
imetelstat
preparing
improved process
stages
cycle
Prior art date
Application number
CL2020000054A
Other languages
English (en)
Spanish (es)
Inventor
Jale Muslehiddinoglu
Dinesh Gala
Jennifer Elizabeth Albaneze-Walker
Original Assignee
Geron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geron Corp filed Critical Geron Corp
Publication of CL2020000054A1 publication Critical patent/CL2020000054A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Specially Adapted For Manufacturing Cables (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL2020000054A 2017-07-10 2020-01-08 Proceso mejorado para preparar imetelstat. CL2020000054A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17180426 2017-07-10

Publications (1)

Publication Number Publication Date
CL2020000054A1 true CL2020000054A1 (es) 2020-10-02

Family

ID=59313083

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020000054A CL2020000054A1 (es) 2017-07-10 2020-01-08 Proceso mejorado para preparar imetelstat.

Country Status (30)

Country Link
US (4) US11332489B2 (fr)
EP (1) EP3652187B1 (fr)
JP (2) JP7199410B2 (fr)
KR (2) KR20240144459A (fr)
CN (1) CN110891961B (fr)
AU (2) AU2018298658B2 (fr)
BR (1) BR112020000410A2 (fr)
CA (2) CA3066968C (fr)
CL (1) CL2020000054A1 (fr)
CO (1) CO2020000096A2 (fr)
CY (1) CY1125351T1 (fr)
DK (1) DK3652187T3 (fr)
EA (1) EA038579B1 (fr)
ES (1) ES2901099T3 (fr)
HR (1) HRP20211940T1 (fr)
HU (1) HUE056722T2 (fr)
IL (1) IL271388B (fr)
LT (1) LT3652187T (fr)
MA (1) MA49555A (fr)
PL (1) PL3652187T3 (fr)
PT (1) PT3652187T (fr)
RS (1) RS62705B1 (fr)
SA (1) SA520410996B1 (fr)
SG (1) SG11201912385VA (fr)
SI (1) SI3652187T1 (fr)
SM (1) SMT202100701T1 (fr)
TW (1) TWI775895B (fr)
UA (1) UA125185C2 (fr)
WO (1) WO2019011829A1 (fr)
ZA (2) ZA201908452B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4523681A1 (fr) * 2019-10-28 2025-03-19 Geron Corporation Sels solides amorphes de 3-(acide gras amido)-2-hydroxy-1-(hydroxy protege)-propane succinyle et leurs procedes de fabrication
CA3155391A1 (fr) 2019-10-28 2021-05-06 Geron Corporation Solides cristallins de 3-palmitoyl-amido -1,2-propanediol et de 3-palmitoyl-amido-2-hydroxy-1-dimethoxytriphenylmethyl ether-propane et leurs procedes de fabrication et d'utilisatio

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1210357T3 (da) 1999-09-10 2008-07-21 Geron Corp Oligonukleotid-N3' -P5' -thiophosphoramidater: syntese og anvendelse deraf
KR101298493B1 (ko) * 2003-09-09 2013-08-21 제론 코포레이션 텔로머라제 억제를 위한 변형 올리고뉴클레오티드
ME02933B (fr) 2004-07-02 2018-04-20 Geron Corp Synthese de monomeres nucleosidiques a groupe 3'-amino protege
PT3449926T (pt) 2009-06-17 2019-11-12 Cold Spring Harbor Laboratory Composições e métodos de modulação de excisões de smn2 em um sujeito
JOP20200257A1 (ar) * 2014-05-01 2017-06-16 Geron Corp تركيبات أوليجو نوكليوتيد وطرق لتحضيرها
ES2999138T3 (en) 2016-06-24 2025-02-24 Biogen Ma Inc Synthesis of thiolated oligonucleotides without a capping step

Also Published As

Publication number Publication date
US20240262854A1 (en) 2024-08-08
US11332489B2 (en) 2022-05-17
CN110891961B (zh) 2023-06-30
JP7199410B2 (ja) 2023-01-05
TWI775895B (zh) 2022-09-01
IL271388A (en) 2020-01-30
JP2020526524A (ja) 2020-08-31
AU2022291626A1 (en) 2023-02-02
KR20200035267A (ko) 2020-04-02
JP2022183382A (ja) 2022-12-08
KR20240144459A (ko) 2024-10-02
SI3652187T1 (sl) 2022-01-31
TW201920228A (zh) 2019-06-01
PT3652187T (pt) 2021-12-16
CA3195922A1 (en) 2019-01-17
WO2019011829A1 (fr) 2019-01-17
KR102709587B1 (ko) 2024-09-27
EA038579B1 (ru) 2021-09-17
CY1125351T1 (el) 2023-03-24
US20240199672A1 (en) 2024-06-20
CO2020000096A2 (es) 2020-01-17
UA125185C2 (uk) 2022-01-26
HRP20211940T1 (hr) 2022-03-18
BR112020000410A2 (pt) 2020-07-14
DK3652187T3 (da) 2021-12-13
CN110891961A (zh) 2020-03-17
CA3066968A1 (fr) 2019-01-17
AU2018298658A1 (en) 2020-01-23
RS62705B1 (sr) 2022-01-31
SMT202100701T1 (it) 2022-01-10
IL271388B (en) 2022-03-01
NZ760372A (en) 2024-08-30
SA520410996B1 (ar) 2023-12-05
ZA201908452B (en) 2022-03-30
HUE056722T2 (hu) 2022-03-28
CA3066968C (fr) 2023-06-13
EP3652187B1 (fr) 2021-09-15
LT3652187T (lt) 2022-01-25
EP3652187A1 (fr) 2020-05-20
PL3652187T3 (pl) 2022-01-31
SG11201912385VA (en) 2020-01-30
MA49555A (fr) 2021-04-28
US20200369702A1 (en) 2020-11-26
AU2018298658B2 (en) 2022-09-29
ZA202110555B (en) 2025-08-27
US20230070069A1 (en) 2023-03-09
US12264174B2 (en) 2025-04-01
ES2901099T3 (es) 2022-03-21
EA202090006A1 (ru) 2020-05-18

Similar Documents

Publication Publication Date Title
CL2020001126A1 (es) Oligonucleótidos para reducir la expresión de pd-l1. (divisional solicitud 202000865)
UY40527A (es) Agentes de iARN para la infección por el virus de la hepatitis B
DOP2020000050A (es) Inhibidores de la ectonucleótido pirofosfatasa-fosfodiesterasa 1 (enpp-1) y usos de los mismos
MX2020004600A (es) Constructos de oligonucleotidos y usos de estos.
CL2018001230A1 (es) Tratamiento de osteoartritis
CL2016003281A1 (es) Ácidos grasos y su uso en conjugación con biomoleculas
CL2017003163A1 (es) Nuevos derivados aminoácido, un proceso para su preparación y composiciones farmacéuticas que los contienen
CO2018000965A2 (es) Copa menstrual ergonómica
UY36212A (es) Moduladores de receptores tipo toll para el tratamiento del vih
BR112015000723A2 (pt) adjuvante de ácido nucléico quiral
CL2020000054A1 (es) Proceso mejorado para preparar imetelstat.
CL2018000158A1 (es) Composiciones y métodos para inhibir la expresión del gen alas1 (divisional de solicitud 20160772)
BR112018011780A2 (pt) ?processo para preparar um composto?
BR112016025196A2 (pt) composições de oligonucleotídeo e métodos de fazê-las
CL2020001562A1 (es) Oligonucleótidos inmunoestimulantes.
MX2018002998A (es) Derivado de acido nucleico que tiene actividad inmunoestimuladora.
ECSP20056232A (es) Régimen posológico del modulador del ensamblaje de la cápside
PE20180498A1 (es) Inmunoglobulinas conjugadas en cys80
MX2017009542A (es) Compuestos quimericos ramificados y lineales, polinucleotidos, usos y metodos para preparacion de los mismos.
MX2020004147A (es) Alcohol secundario alcoxilado.
MX2017000023A (es) Proceso para preparar fenilalcanos sustituidos.
CO2017001614A2 (es) Vacuna en vector recombinante de adenovirus aviar serotipo 9
MX2016009747A (es) Vacunas contra el reovirus aviar.
MX2018005068A (es) Tintes polimericos a base de poli(amidoaminas).
CL2016002737A1 (es) Nucleasa efectora tal para la inactivación específica del correceptor del vih ccr5